Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation.

Cohen JM, Khandavilli S, Camberlein E, Hyams C, Baxendale HE, Brown JS.

PLoS One. 2011;6(10):e25558. doi: 10.1371/journal.pone.0025558. Epub 2011 Oct 7.

2.

The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.

Richards L, Ferreira DM, Miyaji EN, Andrew PW, Kadioglu A.

Immunobiology. 2010 Apr;215(4):251-63. doi: 10.1016/j.imbio.2009.12.004. Epub 2009 Dec 28.

PMID:
20071053
3.

Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation.

Cohen JM, Chimalapati S, de Vogel C, van Belkum A, Baxendale HE, Brown JS.

Vaccine. 2012 Jun 22;30(30):4453-9. doi: 10.1016/j.vaccine.2012.04.080. Epub 2012 May 3.

4.

Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses.

Wilson R, Cohen JM, Jose RJ, de Vogel C, Baxendale H, Brown JS.

Mucosal Immunol. 2015 May;8(3):627-39. doi: 10.1038/mi.2014.95. Epub 2014 Oct 29.

5.

Lack of cross-protection against invasive pneumonia caused by heterologous strains following murine Streptococcus pneumoniae nasopharyngeal colonisation despite whole cell ELISAs showing significant cross-reactive IgG.

Cohen JM, Wilson R, Shah P, Baxendale HE, Brown JS.

Vaccine. 2013 May 1;31(19):2328-32. doi: 10.1016/j.vaccine.2013.03.013. Epub 2013 Mar 21.

PMID:
23523406
6.

Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-γ-mediated immunity.

Marqués JM, Rial A, Muñoz N, Pellay FX, Van Maele L, Léger H, Camou T, Sirard JC, Benecke A, Chabalgoity JA.

Immunobiology. 2012 Apr;217(4):420-9. doi: 10.1016/j.imbio.2011.10.012. Epub 2011 Nov 23.

PMID:
22204818
7.

Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies.

Saeland E, Vidarsson G, Jonsdottir I.

Microb Pathog. 2000 Aug;29(2):81-91.

PMID:
10906263
8.

Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.

Xu Q, Surendran N, Verhoeven D, Klapa J, Ochs M, Pichichero ME.

Vaccine. 2015 Feb 18;33(8):993-1000. doi: 10.1016/j.vaccine.2015.01.014. Epub 2015 Jan 15.

PMID:
25597944
9.
10.
11.

Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.

Chimalapati S, Cohen J, Camberlein E, Durmort C, Baxendale H, de Vogel C, van Belkum A, Brown JS.

Infect Immun. 2011 Dec;79(12):4965-76. doi: 10.1128/IAI.05923-11. Epub 2011 Sep 26.

12.

Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats.

Stack AM, Malley R, Thompson CM, Kobzik L, Siber GR, Saladino RA.

J Infect Dis. 1998 Apr;177(4):986-90.

PMID:
9534972
13.

Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization.

Musher DM, Groover JE, Reichler MR, Riedo FX, Schwartz B, Watson DA, Baughn RE, Breiman RF.

Clin Infect Dis. 1997 Mar;24(3):441-6.

PMID:
9114197
14.

PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease.

Ramos-Sevillano E, Urzainqui A, de Andrés B, González-Tajuelo R, Domenech M, González-Camacho F, Sánchez-Madrid F, Brown JS, García E, Yuste J.

PLoS Pathog. 2016 Mar 14;12(3):e1005500. doi: 10.1371/journal.ppat.1005500. eCollection 2016 Mar 14.

15.

Sortase A confers protection against Streptococcus pneumoniae in mice.

Gianfaldoni C, Maccari S, Pancotto L, Rossi G, Hilleringmann M, Pansegrau W, Sinisi A, Moschioni M, Masignani V, Rappuoli R, Del Giudice G, Ruggiero P.

Infect Immun. 2009 Jul;77(7):2957-61. doi: 10.1128/IAI.01516-08. Epub 2009 May 11.

16.

Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins.

Cao J, Zhang X, Gong Y, Zhang Y, Cui Y, Lai X, Yin Y, Li M, Li D, Zhang L.

Vaccine. 2013 Aug 2;31(35):3564-71. doi: 10.1016/j.vaccine.2013.05.061. Epub 2013 May 29.

PMID:
23727004
17.

Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.

Zeng L, Liu Y, Wang H, Liao P, Song Z, Gao S, Wu Y, Zhang X, Yin Y, Xu W.

Vaccine. 2015 Feb 18;33(8):1008-16. doi: 10.1016/j.vaccine.2015.01.013. Epub 2015 Jan 14.

PMID:
25595867
18.

The role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia.

Jounblat R, Clark H, Eggleton P, Hawgood S, Andrew PW, Kadioglu A.

Respir Res. 2005 Oct 28;6:126.

20.

Pneumococcal pneumonia suppresses allergy development but preserves respiratory tolerance in mice.

Hartmann C, Behrendt AK, Henken S, Wölbeling F, Maus UA, Hansen G.

Immunol Lett. 2015 Mar;164(1):44-52. doi: 10.1016/j.imlet.2014.12.001. Epub 2015 Jan 6.

PMID:
25576460

Supplemental Content

Support Center